Dong Chune Christopher Chung - Jul 21, 2022 Form 4 Insider Report for NATUS MEDICAL INC (NTUS)

Role
Chief Medical Officer
Signature
/s/ DOUGLAS BALOG by POWER OF ATTORNEY
Stock symbol
NTUS
Transactions as of
Jul 21, 2022
Transactions value $
-$3,246,344
Form type
4
Date filed
7/21/2022, 05:06 PM
Previous filing
Jan 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTUS Common Stock, $0.001 par value per share Award $0 +35.1K +72.55% $0.00 83.4K Jul 21, 2022 Direct F1
transaction NTUS Common Stock, $0.001 par value per share Disposed to Issuer -$2.79M -83.4K -100% $33.50 0 Jul 21, 2022 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NTUS Nonqualified Stock Option Disposed to Issuer -$453K -35.4K -100% $12.82 0 Jul 21, 2022 Common Stock 35.4K $20.68 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Dong Chune Christopher Chung is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Represents the number of shares of Common Stock subject to performance-based stock unit awards that vested and were settled as a result of the merger ("Merger") pursuant to the previously announced Agreement and Plan of Merger, dated April 17, 2022, between Prince Parent Inc. ("Parent"), Prince Mergerco Inc, and Issuer ("Merger Agreement").
F2 Disposed of as a result of the Merger.
F3 Each share of Common Stock, including shares underlying equity awards, was cancelled pursuant to the Merger Agreement in exchange for the right to receive the cash consideration provided in the Merger Agreement, subject to applicable tax withholding.
F4 This option, which provided for vesting in four equal annual installments beginning November 13, 2021, was (to the extent not previously exercised) cancelled in the Merger pursuant to the Merger Agreement in exchange for a cash payment, per option share, representing the difference between the per share exercise price of the option and the per share cash consideration provided in the Merger Agreement ($33.50), subject to applicable tax withholding.